24 May 2013
Keywords: merck, s-p, file, usa, cholesterol, drug, co
Article | 07 January 2002
Merck & Co and Schering-Plough have submitted a marketing application inthe USA for Zetia (ezetimibe), a cholesterol-absorption inhibitor
discovered by S-P ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
7 January 2002
21 January 2002
23 May 2013
© 2013 thepharmaletter.com